These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 27765819)
21. IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation. Cai Q; Banerjee S; Cervini A; Lu J; Hislop AD; Dzeng R; Robertson ES PLoS Pathog; 2013 Oct; 9(10):e1003751. PubMed ID: 24204280 [TBL] [Abstract][Full Text] [Related]
22. N Protein of Viral Hemorrhagic Septicemia Virus Suppresses STAT1-Mediated MHC Class II Transcription to Impair Antigen Presentation in Sea Perch, Lu X; Li W; Guo J; Jia P; Zhang W; Yi M; Jia K J Immunol; 2022 Mar; 208(5):1076-1084. PubMed ID: 35181639 [TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3. Butler LM; Jeffery HC; Wheat RL; Long HM; Rae PC; Nash GB; Blackbourn DJ J Virol; 2012 Jul; 86(13):7158-66. PubMed ID: 22532676 [TBL] [Abstract][Full Text] [Related]
24. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. Nikodemova M; Watters JJ; Jackson SJ; Yang SK; Duncan ID J Biol Chem; 2007 May; 282(20):15208-16. PubMed ID: 17395590 [TBL] [Abstract][Full Text] [Related]
25. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines. Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572 [TBL] [Abstract][Full Text] [Related]
26. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter. Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445 [TBL] [Abstract][Full Text] [Related]
27. Block of Stat-1 activation in macrophages phagocytosing bacteria causes reduced transcription of CIITA and consequent impaired antigen presentation. Barbaro Ade L; Tosi G; Frumento G; Bruschi E; D'Agostino A; Valle MT; Manca F; Accolla RS Eur J Immunol; 2002 May; 32(5):1309-18. PubMed ID: 11981818 [TBL] [Abstract][Full Text] [Related]
28. Brucella abortus induces apoptosis of human T lymphocytes. Velásquez LN; Delpino MV; Ibañez AE; Coria LM; Miraglia MC; Scian R; Cassataro J; Giambartolomei GH; Barrionuevo P Microbes Infect; 2012 Jul; 14(7-8):639-50. PubMed ID: 22387699 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathway. Velásquez LN; Milillo MA; Delpino MV; Trotta A; Mercogliano MF; Pozner RG; Schillaci R; Elizalde PV; Giambartolomei GH; Barrionuevo P Immunol Cell Biol; 2017 Apr; 95(4):388-398. PubMed ID: 27811842 [TBL] [Abstract][Full Text] [Related]
30. Recombinant Lipoprotein Rv1016c Derived from Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375 [TBL] [Abstract][Full Text] [Related]
31. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha. Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975 [TBL] [Abstract][Full Text] [Related]
32. Interferon Regulatory Factors 1 and 2 Play Different Roles in MHC II Expression Mediated by CIITA in Grass Carp, Lu XB; Wang ZX; Liu SB; Zhang XY; Lu LF; Li S; Chen DD; Nie P; Zhang YA Front Immunol; 2019; 10():1106. PubMed ID: 31191518 [TBL] [Abstract][Full Text] [Related]
33. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells. Meissner M; Whiteside TL; Kaufmann R; Seliger B Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823 [TBL] [Abstract][Full Text] [Related]
34. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts. Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216 [TBL] [Abstract][Full Text] [Related]
35. Beyond its preferential niche: Brucella abortus RNA down-modulates the IFN-γ-induced MHC-I expression in epithelial and endothelial cells. Serafino A; Bertinat YA; Bueno J; Pittaluga JR; Birnberg Weiss F; Milillo MA; Barrionuevo P PLoS One; 2024; 19(7):e0306429. PubMed ID: 38980867 [TBL] [Abstract][Full Text] [Related]
36. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. Wang Y; Curry HM; Zwilling BS; Lafuse WP J Immunol; 2005 May; 174(9):5687-94. PubMed ID: 15843570 [TBL] [Abstract][Full Text] [Related]
37. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. Abendroth A; Slobedman B; Lee E; Mellins E; Wallace M; Arvin AM J Virol; 2000 Feb; 74(4):1900-7. PubMed ID: 10644363 [TBL] [Abstract][Full Text] [Related]
38. Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon. Gao J; De BP; Han Y; Choudhary S; Ransohoff R; Banerjee AK J Virol; 2001 Feb; 75(3):1124-31. PubMed ID: 11152485 [TBL] [Abstract][Full Text] [Related]
39. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831 [TBL] [Abstract][Full Text] [Related]
40. Brucella abortus regulates bovine macrophage-T-cell interaction by major histocompatibility complex class II and interleukin-1 expression. Splitter GA; Everlith KM Infect Immun; 1989 Apr; 57(4):1151-7. PubMed ID: 2494112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]